Community Oncology Alliance

 

2021 Community Oncology Conference
12:52

2021 Community Oncology Conference

Opportunities & Challenges in TNBC: Navigating Immune CPI Efficacy Data

FEATURING Joyce O'Shaughnessy
  • 444 views
  • June 18, 2021
15:12

2021 Community Oncology Conference

Advances in HER2+ BC: Overview of Current Data

FEATURING Joyce O'Shaughnessy
  • 687 views
  • June 11, 2021
08:18

2021 Community Oncology Conference

2021 Update on Frontline CLL: Comparing Treatment Outcomes With BTK Inhibitors

FEATURING Jeff Sharman
  • 10 views
  • June 4, 2021
17:51

2021 Community Oncology Conference

2021 Update on Targeting Pathways in Frontline CLL: BTK Resistance, Efficacy Data on BCL-2, CD20, and PI3K Inhibitors

FEATURING Jeff Sharman
  • 13 views
  • June 4, 2021
13:21

2021 Community Oncology Conference

New Advances in KRASm NSCLC: Considering Sotorasib & Adagrasib Efficacy Data

FEATURING Alex Spira
  • 235 views
  • May 24, 2021
  • 1
14:20

2021 Community Oncology Conference

2021 Update on EGFR Exon20ins in mNSCLC: Bispecific Antibody vs. TKI Therapy Outcomes in Previously Treated Disease

FEATURING Alex Spira
  • 127 views
  • May 24, 2021
08:19

2021 Community Oncology Conference

2021 Data on HCC & mCRC: Atezo+Bev vs. Sorafenib in Unresectable HCC; Pembro vs. Chemo for MMR/MSI-H CRC, Encorafenib+Cetuximab in BRAF V600E Mutations, Trastuzumab+Tucatinib for HER2-Amplified CRC

FEATURING Johanna Bendell
  • 93 views
  • May 5, 2021
05:11

2021 Community Oncology Conference

2021 Biliary Tract Cancer Updates: Ivosidenib in Chemo-Refractory IDH1m Cholangiocarcinoma, Infigratinib for Unresectable Locally Advanced/Metastatic Disease

FEATURING Johanna Bendell
  • 218 views
  • May 4, 2021
  • 1
05:17

2021 Community Oncology Conference

2021 Pancreatic Cancer Updates: Preoperative mFOLFIRINOX vs. Gem/nabP for Resectable Disease, Neoadjuvant XRT, Olaparib for Metastatic Disease

FEATURING Johanna Bendell
  • 27 views
  • May 4, 2021
08:38

2021 Community Oncology Conference

2021 GE Cancer Updates: Nivo for Stage 2/3 EC/GEJC, Chemo+/-Pembro in Advanced EAC/ESCC, Nivo+Ipi/Chemo/Nivo+Chemo for 1L GE/GEJ Cancers, Trastuzumab Deruxtecan in Advanced HER2+ Gastric Cancer

FEATURING Johanna Bendell
  • 516 views
  • May 4, 2021
  • 4
02:31

2021 Community Oncology Conference

Guide to Current Biomarker Testing for GI Cancers and Improvements in OS with IO

FEATURING Johanna Bendell
  • 50 views
  • May 4, 2021
39:14

2021 Community Oncology Conference

New Coding & Reimbursement Changes in 2021: Best Practices, Medical Decision Making, Transitional/Chronic Care Management

FEATURING Johnetta Blakely, Roberta Buell, Bo Gamble, Barbara McAneny
  • 26 views
  • April 28, 2021
40:03

2021 Community Oncology Conference

How to Maximize Practice Efficiencies and Reduce Costs: What Your Practice Can Do Tomorrow?

FEATURING Bo Gamble, Marcus Neubauer, Todd O’Connell, Alti Rahman
  • 86 views
  • April 28, 2021
  • 1
21:33

2021 Community Oncology Conference

Hospital Drug Pricing: Is Pricing Transparency Going to Change the Current Situation? Should Drugs Be Shifted Out of Hospitals? Are Biosimilars More Likely to Be Adopted?

FEATURING Aharon Gal
  • 9 views
  • April 28, 2021
34:38

2021 Community Oncology Conference

How Employers Approach Cancer Care & Benefit Design: Strategies, Biomarker Testing, Payment Reform, Direct Contracting, Telehealth

FEATURING Robert Baird, Jr., Bret Jackson, Ruth Opdycke, Candace Shaffer
  • 3 views
  • April 28, 2021
29:26

2021 Community Oncology Conference

Ensuring & Measuring Quality With a New Model for Cancer Care: Payment Reform Models, Oncology Medical Home in OCM 2.0

FEATURING Michael Diaz, Bo Gamble, Lalan Wilfong
  • 4 views
  • April 28, 2021
28:47

2021 Community Oncology Conference

Palliative Care in Oncology: Can It Improve QoL and Reduce the Use of Medical Services? How Does It Compare to the Usual Care for Newly Diagnosed Advanced Cancers?

FEATURING Morvarid Rezaie
  • 4 views
  • April 28, 2021
12:27

2021 Community Oncology Conference

2021 IO & Gene Therapy Updates: Cancer Medicine and Vaccines in Development, CRISPR, CAR-T, Barriers to Trial Enrollment, PRiMER Program, MOSS

FEATURING David Spigel
  • 17 views
  • April 28, 2021
13:31

2021 Community Oncology Conference

2021 Updates on Theranostics in Oncology: How Do Diagnostic & Therapeutic Components Correlate? What Is Lu-177 OS Data in Prostate Cancer Patients?

FEATURING Tony Abraham
  • 12 views
  • April 28, 2021
37:09

2021 Community Oncology Conference

Biomarker Testing Updates: NGS vs. CGP, Who to Test, Predictive Biomarkers, How to Avoid Barriers

FEATURING Martin Dietrich, Bobby Green, Geoffrey Oxnard, Anthony Sireci, Byeong Yoon
  • 398 views
  • April 28, 2021
  • 3
38:48

2021 Community Oncology Conference

Biosimilars in Cancer Care: Challenges & Opportunities From Research to Utilization? Removing Barriers to Biosimilar Adoption, Prices and Cost Savings

FEATURING E. Randolph Broun, Sonia Oskouei, Kathy Oubre, Sandeep Parsad
  • 9 views
  • April 28, 2021
52:02

2021 Community Oncology Conference

COVID-19 Pandemic Management: How Has Cancer Care Evolved and Innovated During the COVID-19 Pandemic? How Are Physicians Managing Their Practices and Revising Communication For Best Outcomes?

FEATURING Lucio Gordan, James Perry, Jennifer Pichoske
  • 13 views
  • April 27, 2021